Epigral Limited Stock Price Today (NSE: EPIGRAL)
Fundamental Score
Epigral Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Epigral Limited share price today is ₹1084.00, down 0.75% on NSE/BSE as of 16 September 2026. Epigral Limited (EPIGRAL) is a Small-cap company in the Specialty Chemicals sector with a market capitalisation of ₹4.68K (Cr). The 52-week high for EPIGRAL share price is ₹1808.80 and the 52-week low is ₹807.00. At a P/E ratio of 17.26x, EPIGRAL is currently trading below its industry average P/E of 31.95x. The company has a Return on Equity (ROE) of 16.09% and a debt-to-equity ratio of 0.25.
Epigral Limited Share Price Chart — NSE/BSE Historical Performance
Epigral Limited share price chart: 5.61% return over the past month. 52-week high ₹1808.80, 52-week low ₹807.00.
Epigral Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹1092.20 | ₹1092.20 | ₹1054.10 | ₹1084.00 | 21.63K (Cr) | |
| ₹1134.80 | ₹1136.60 | ₹1076.70 | ₹1092.20 | 49.51K (Cr) | |
| ₹1155.90 | ₹1155.90 | ₹1117.00 | ₹1131.10 | 22.43K (Cr) | |
| ₹1166.10 | ₹1175.00 | ₹1140.00 | ₹1149.80 | 36.00K (Cr) | |
| ₹1185.80 | ₹1189.80 | ₹1160.00 | ₹1163.90 | 32.83K (Cr) | |
| ₹1215.00 | ₹1215.00 | ₹1172.40 | ₹1189.80 | 30.44K (Cr) | |
| ₹1228.00 | ₹1231.80 | ₹1176.10 | ₹1179.80 | 50.80K (Cr) | |
| ₹1230.00 | ₹1254.80 | ₹1214.50 | ₹1219.70 | 48.19K (Cr) | |
| ₹1236.80 | ₹1254.80 | ₹1221.20 | ₹1236.70 | 39.18K (Cr) | |
| ₹1235.00 | ₹1240.80 | ₹1206.20 | ₹1230.60 | 35.16K (Cr) |
Epigral Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹1208.60 | ₹1254.80 | ₹1054.10 | ₹1084.00 | -10.31% | |
| ₹1095.00 | ₹1264.80 | ₹1054.60 | ₹1203.30 | +9.89% | |
| ₹1085.00 | ₹1214.00 | ₹969.00 | ₹1088.70 | +0.34% | |
| ₹1178.00 | ₹1190.00 | ₹1051.90 | ₹1084.10 | -7.97% | |
| ₹1225.00 | ₹1400.00 | ₹1146.24 | ₹1155.90 | -5.64% | |
| ₹822.00 | ₹1236.95 | ₹818.80 | ₹1215.65 | +47.89% | |
| ₹850.00 | ₹909.00 | ₹807.00 | ₹810.45 | -4.65% | |
| ₹975.70 | ₹1073.50 | ₹885.00 | ₹891.80 | -8.60% | |
| ₹1232.70 | ₹1270.30 | ₹996.00 | ₹1043.10 | -15.38% | |
| ₹1518.50 | ₹1535.20 | ₹1212.80 | ₹1220.10 | -19.65% | |
| ₹1690.00 | ₹1709.00 | ₹1398.00 | ₹1511.70 | -10.55% | |
| ₹1691.10 | ₹1771.00 | ₹1661.00 | ₹1689.70 | -0.08% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Epigral Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Epigral Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of EPIGRAL across key market metrics for learning purposes.
Positive Indicators
14 factors identified
Strong Return on Equity (16.09%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (15.17%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (27.84%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 17.26 vs Industry: 31.95)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Strong Revenue Growth (16.29%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (24.99% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (25.29% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (26.46% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.25)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (5.75x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Healthy Liquidity Position (Current Ratio: 1.57)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Strong Cash Generation (₹323.67 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (68.83%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
2 factors identified
Profit Decline Concern (-37.93%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Limited Institutional Interest (FII+DII: 6.44%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
Epigral Limited vs Specialty Chemicals Peers
Peer Comparison - Specialty Chemicals
Compare Epigral Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Epigral LimitedEpigral Limited...Selected✓ EPIGRAL • 543332 | 69.4/100 | ₹1084.00₹1084 | ₹4676.38₹4676.38 | 17.26Average 17.3 Average | 16.09%Good 16.09% Good | 15.17%Good 15.17% Good | 0.25Excellent 0.3 Excellent | 26.46%Excellent 26.46% Excellent | 24.99%Excellent 24.99% Excellent | 0.48% |
Pidilite Industries LimitedPidilite Indust... PIDILITIND • 500331 | 65.3/100 | ₹1573.50₹1574 | ₹160150.83₹160150.83 | 60.47Average 60.5 Average | 23.79%Excellent 23.79% Excellent | 29.92%Excellent 29.92% Excellent | 0.01Excellent 0.0 Excellent | 16.70%Excellent 16.70% Excellent | 14.89%Good 14.89% Good | 0.73% |
Gujarat Fluorochemicals LimitedGujarat Fluoroc... FLUOROCHEM • 542812 | 42.9/100 | ₹4683.60₹4684 | ₹51519.60₹51519.60 | 84.10Average 84.1 Average | 7.65%Poor 7.65% Poor | 10.87%Average 10.87% Average | 0.28Excellent 0.3 Excellent | 36.34%Excellent 36.34% Excellent | 13.52%Good 13.52% Good | 0.07% |
Navin Fluorine International LimitedNavin Fluorine ... NAVINFLUOR • 532504 | 62.7/100 | ₹8858.00₹8858 | ₹45441.54₹45441.54 | 57.45Average 57.5 Average | 20.11%Excellent 20.11% Excellent | 21.48%Excellent 21.48% Excellent | 0.31Excellent 0.3 Excellent | 20.84%Excellent 20.84% Excellent | 22.95%Excellent 22.95% Excellent | 0.20% |
Deepak Nitrite LimitedDeepak Nitrite ... DEEPAKNTR • 506401 | 32.8/100 | ₹1665.00₹1665 | ₹22710.60₹22710.60 | 28.99Average 29.0 Average | 9.81%Poor 9.81% Poor | 11.31%Average 11.31% Average | 0.26Excellent 0.3 Excellent | -6.63%Poor -6.63% Poor | 12.59%Good 12.59% Good | 0.44% |
Aether Industries LimitedAether Industri... AETHER • 543534 | 36.3/100 | ₹1633.30₹1633 | ₹21676.01₹21676.01 | 91.91Average 91.9 Average | 9.38%Poor 9.38% Poor | 12.78%Average 12.78% Average | 0.18Excellent 0.2 Excellent | — — | — — | 0.00% |
Atul LimitedAtul Limited... ATUL • 500027 | 58.2/100 | ₹6282.00₹6282 | ₹18494.21₹18494.21 | 23.25Average 23.3 Average | 11.47%Average 11.47% Average | 14.24%Average 14.24% Average | 0.03Excellent 0.0 Excellent | 54.89%Excellent 54.89% Excellent | 10.95%Good 10.95% Good | 0.49% |
Aarti Industries LimitedAarti Industrie... AARTIIND • 524208 | 38.7/100 | ₹497.95₹498 | ₹18061.64₹18061.64 | 34.01Average 34.0 Average | 7.25%Poor 7.25% Poor | 8.86%Poor 8.86% Poor | 0.83Good 0.8 Good | -4.35%Poor -4.35% Poor | 12.96%Good 12.96% Good | 0.20% |
BASF India LimitedBASF India Limi... BASF • 500042 | 52.2/100 | ₹3802.00₹3802 | ₹16458.86₹16458.86 | 25.57Average 25.6 Average | 0.00%Poor 0.00% Poor | 14.04%Average 14.04% Average | 0.00Excellent 0.0 Excellent | 7.67%Good 7.67% Good | 9.35%Good 9.35% Good | 0.68% |
Fine Organic Industries LimitedFine Organic In... FINEORG • 541557 | 62.09999999999999/100 | ₹5145.00₹5145 | ₹15774.57₹15774.57 | 36.01Average 36.0 Average | 16.82%Good 16.82% Good | 21.91%Excellent 21.91% Excellent | 0.02Excellent 0.0 Excellent | 28.23%Excellent 28.23% Excellent | 15.86%Excellent 15.86% Excellent | 0.21% |
Anupam Rasayan India LimitedAnupam Rasayan ... ANURAS • 543275 | 33.3/100 | ₹1224.50₹1225 | ₹13940.69₹13940.69 | 79.62Average 79.6 Average | 5.50%Poor 5.50% Poor | 9.10%Poor 9.10% Poor | 0.54Good 0.5 Good | 19.33%Excellent 19.33% Excellent | 23.88%Excellent 23.88% Excellent | 0.06% |
Top Specialty Chemicals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Pidilite Industries Limited share price160150.83 Cr
- Gujarat Fluorochemicals Limited share price51519.60 Cr
- Navin Fluorine International Limited share price45441.54 Cr
- Deepak Nitrite Limited share price22710.60 Cr
- Aether Industries Limited share price21676.01 Cr
Epigral Limited PE Ratio History
Historical price-to-earnings ratio for EPIGRAL — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹84.68 | ₹1220.10 | 14.4x |
| FY 2024 | ₹47.14 | ₹1896.20 | 40.2x |
| FY 2023 | ₹85.03 | ₹977.05 | 11.5x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Epigral Limited Dividend History
Annual cash dividends paid by EPIGRAL — dividend yield 0.48%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹41.86 Cr |
| FY 2024 | ₹25.12 Cr |
| FY 2023 | ₹24.22 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Epigral Limited Quarterly Performance
Latest quarterly metrics for EPIGRAL — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
16.29%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-37.93%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
24.99%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
26.46%
Compounded annual net profit growth over 5 years
Epigral Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for EPIGRAL — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Epigral Limited Financial Statements
Annual income statement, balance sheet and cash flow for Epigral Limited (EPIGRAL) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Epigral Limited
About EPIGRAL (Epigral Limited)
Epigral Ltd is a dynamic force in the specialty chemicals arena, carving a niche for itself through innovative manufacturing and a commitment to global reach. The company stands as... a vertically integrated entity, mastering the complexities of the chlor-alkali process to produce a diverse range of high-value derivatives. More than just a manufacturer, Epigral is a creator of essential building blocks for a multitude of industries, transforming raw materials into specialized compounds that fuel progress and enable advanced applications. Epigral's unwavering focus on quality, safety, and sustainability ensures that its products not only meet but exceed industry standards, establishing it as a trusted partner in a competitive market. At the heart of Epigral's operations lies a dedication to harnessing the power of chlorine and its derivatives. From the resilient chlorinated polyvinyl chloride (CPVC) resins and compounds that fortify infrastructure to the reactive epichlorohydrin that forms the basis of countless epoxy resins, Epigral's product portfolio is both diverse and strategically focused. The company also demonstrates expertise in the chloromethanes value chain and produces hydrogen peroxide, caustic soda and potash, chlorine and hydrogen, offering a comprehensive suite of chemicals indispensable to various industrial processes. Epigral's commitment to self-sufficiency is evident in its captive power plant (CPP) and chlorotoluene value chain and its strategic investments in renewable energy through wind-solar hybrid power plants. Epigral's impact resonates across a broad spectrum of applications. Its CPVC resins and compounds are pivotal in the manufacturing of robust CPVC pipes and fittings, ensuring reliable fluid transport. Furthermore, its chemical solutions find application in diverse sectors, including windmills, construction, paints, and pharmaceuticals, solidifying Epigral's position as a key supplier in the global market. Through continuous innovation and a customer-centric approach, Epigral is dedicated to providing solutions that drive efficiency, enhance performance, and contribute to a more sustainable future for its partners and the planet.
Company Details
Key Leadership
EPIGRAL Share Price: Frequently Asked Questions
What is the current share price of Epigral Limited?
Epigral Limited (EPIGRAL) trades at ₹1084.00 on NSE and BSE. Market cap ₹4.68K (Cr). Educational data only.
What is the P/E ratio of Epigral Limited?
Epigral Limited has a P/E of 17.26x vs industry average 31.95x.
What is the Bull Run score for Epigral Limited?
Epigral Limited has a Bull Run score of 69.4/100 based on 25+ financial parameters.
Does Epigral Limited pay dividends?
Epigral Limited has a dividend yield of 0.48%. Past dividends don't guarantee future payments.
What is the ROE of Epigral Limited?
Epigral Limited has ROE of 16.09%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Epigral Limited?
Epigral Limited has debt-to-equity of 0.25.
Is Epigral Limited a good investment?
Bull Run gives Epigral Limited a score of 69.4/100. This is not investment advice — consult a SEBI-registered advisor.